Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-206,325
Closed -$16.4M 51
2015
Q2
$16.4M Sell
206,325
-2,050,860
-91% -$174M 0.18% 47
2015
Q1
$185M Hold
2,257,185
2.11% 19
2014
Q4
$200M Buy
2,257,185
+197,540
+10% +$17.9M 2.43% 18
2014
Q3
$202M Sell
2,059,645
-1,060,325
-34% -$119M 2.39% 23
2014
Q2
$400M Hold
3,119,970
3.95% 5
2014
Q1
$383M Hold
3,119,970
4.24% 2
2013
Q4
$342M Hold
3,119,970
3.52% 8
2013
Q3
$303M Hold
3,119,970
3.62% 8
2013
Q2
$280M Buy
+3,119,970
New +$257M 3.38% 8

Other funds holding ENOV

Blue Ridge Capital's ENOV Position: Q3 2015 in Review

Blue Ridge Capital sold out of Enovis (ENOV) in Q3 2015, closing a stake of 206,325 shares — an estimated $16.4M sold.

Blue Ridge Capital first reported a position in ENOV in Q2 2013 and held it in 9 quarters. The position peaked at $400M in Q2 2014. 212 funds tracked by Wall St. Rank hold ENOV as of Q3 2015.

  • Blue Ridge Capital reported no remaining Enovis position as of Q3 2015 after selling out during the quarter.
  • Blue Ridge Capital sold 206,325 Enovis shares in Q3 2015, an estimated $16.4M.
  • Blue Ridge Capital first reported a position in Enovis in Q2 2013 and held it in 9 quarters.
  • Blue Ridge Capital's Enovis position peaked at $400M in Q2 2014.
  • 212 funds tracked by Wall St. Rank held Enovis as of Q3 2015.

Based on Blue Ridge Capital's 13F filing for Q3 2015, filed 16 Nov 2015.